Concentrate of Recombinant Coagulation Factor Ix Tender - 146135469

Procurement Summary

Country: Poland

Summary: Concentrate of Recombinant Coagulation Factor Ix at Least 2Nd Generation with Delivery to Regional Blood Donation and Blood Treatment Centers; Procedure Code: Zzp.Zp.411.117.2026 Parts: 1÷3

Deadline: 13 Aug 2026

Posting Date: 29 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 146135469

Document Ref. No.: 525368-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33621000 - Medicinal products for the blood and blood-forming organs

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Part 1. Recombinant coagulation factor IX minimum 2nd generation concentrate with delivery to Regional Blood Donation and Blood Treatment Centers. Part 2. Concentrate of recombinant coagulation factor IX at least 2nd generation with delivery to Regional Blood Donation and Blood Treatment Centers. Part 3. Concentrate of recombinant coagulation factor IX at least 2nd generation with delivery to Regional Blood Donation and Blood Treatment Centers. The subject of the order is the supply of concentrate recombinant coagulation factor IX of at least the second generation to secure the continuity of treatment of patients with hemophilia B - hereinafter "coagulation factor", with the availability category Rp or Rpz, to those indicated by the National Blood Center (hereinafter NCK) or other authorized entity of direct recipients - Regional Blood Donation and Blood Treatment Centers (hereinafter referred to as RCKiK), on the terms specified in the SWZ content. 1. The subject of the order is the supply of recombinant clotting factor IX at least 2nd generation concentrate in order to secure the continuity of treatment of patients with hemophilia B - hereinafter referred to as "coagulation factor", with the availability category Rp or Rpz, to direct recipients - Regional Centers - indicated by the National Blood Center (hereinafter NCK) or other authorized entity Blood Donation and Blood Treatment (hereinafter referred to as RCKiK), on the terms specified in the SWZ. 2. Total quantity (purchase quantity): 300, 000 IU. 3. Proportions of doses in each delivery - in accordance with SWZ. 4. Clotting factor concentrate...
Document Type: Contract Notice Reference Number: ZZP.ZP.411.117.2026 Contract Type: supplies Authority Type: cga Doc Title: Recombinant coagulation factor IX minimum 2nd generation concentrate with delivery to Regional Blood Donation Centers and Blood therapy; procedure code: ZZP.ZP.411.117.2026 parts: 1÷3 Dispatch Date: 2026-07-27 Publish Date: 2026-07-29 Submission Date: 2026-08-13

Documents

 Tender Notice